Pediatrics Spanish Registry of Percutaneous Melody Pulmonary Valve Implantation in Patients Younger Than 18 Years
| Autor: | Jose M. Velasco, Manuel Pan, Pedro Betrián, Federico Gutiérrez-Larraya, Juan Alcíbar, José Luis Zunzunegui, María Jesús del Cerro, Jose F. Coserria, Fernando Rueda, Ruth Solana-Gracia |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
Reoperation Cardiac Catheterization Pediatrics medicine.medical_specialty Percutaneous Adolescent 030204 cardiovascular system & hematology Prosthesis Design 03 medical and health sciences 0302 clinical medicine Interquartile range Pulmonary Valve Replacement Internal medicine medicine Humans Registries 030212 general & internal medicine Retrospective Studies Tetralogy of Fallot Bioprosthesis Heart Valve Prosthesis Implantation Pulmonary Valve business.industry Mortality rate General Medicine medicine.disease Pulmonary Valve Insufficiency Surgery Pulmonary Valve Stenosis Treatment Outcome medicine.anatomical_structure Heart Valve Prosthesis Infective endocarditis Pulmonary valve Cardiology Female business Complication |
| Zdroj: | Revista Española de Cardiología (English Edition). 71:283-290 |
| ISSN: | 1885-5857 |
| DOI: | 10.1016/j.rec.2017.07.013 |
| Popis: | Introduction and objectives A decade has passed since the first Spanish percutaneous pulmonary Melody valve implant (PPVI) in March 2007. Our objective was to analyze its results in terms of valvular function and possible mid-term follow-up complications. Methods Spanish retrospective descriptive multicenter analysis of Melody PPVI in patients Results Nine centers were recruited with a total of 81 PPVI in 77 pediatric patients, whose median age and weight were 13.3 years (interquartile range [IQR], 9.9-15.4) and 46 kg (IQR, 27-63). The predominant cardiac malformation was tetralogy of Fallot (n = 27). Most of the valves were implanted on conduits, especially bovine xenografts (n = 31). The incidence of intraprocedure and acute complications was 6% and 8%, respectively (there were no periprocedural deaths). The median follow-up time was 2.4 years (IQR, 1.1-4.9). Infective endocarditis (IE) was diagnosed in 4 patients (5.6%), of which 3 required surgical valve explant. During follow-up, the EI-related mortality rate was 1.3%. At 5 years of follow-up, 80% ± 6.9% and 83% ± 6.1% of the patients were free from reintervention and pulmonary valve replacement. Conclusions Melody PPVI was safe and effective in pediatric patients with good short- and mid-term follow-up hemodynamic results. The incidence of IE during follow-up was relatively low but was still the main complication. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect